Gemcitabine and Cisplatin Induction Chemotherapy in Nasopharyngeal Carcinoma.
Yuan ZhangLei ChenGuo-Qing HuNing ZhangXiao-Dong ZhuKun-Yu YangFeng JinMei ShiYu-Pei ChenWei-Han HuZhi-Bin ChengSi-Yang WangYe TianXi-Cheng WangYan SunJin-Gao LiWen-Fei LiYu-Hong LiLing-Long TangYan-Ping MaoGuan-Qun ZhouRui SunXu LiuRui GuoGuo-Xian LongShao-Qiang LiangLing LiJing HuangJin-Hua LongJian ZangQiao-Dan LiuLi ZouQiong-Fei SuBao-Min ZhengYun XiaoYing GuoFei HanHao-Yuan MoJia-Wei LvXiao-Jing DuCheng XuNa LiuYing-Qin LiMatthew Chin Heng ChuaFang-Yun XieYing SunJun MaPublished in: The New England journal of medicine (2019)
Induction chemotherapy added to chemoradiotherapy significantly improved recurrence-free survival and overall survival, as compared with chemoradiotherapy alone, among patients with locoregionally advanced nasopharyngeal carcinoma. (Funded by the Innovation Team Development Plan of the Ministry of Education and others; ClinicalTrials.gov number, NCT01872962.).